Froestl W, Mickel S J, Hall R G, von Sprecher G, Strub D, Baumann P A, Brugger F, Gentsch C, Jaekel J, Olpe H R
Research and Development Department, CIBA-GEIGY AG, Basel, Switzerland.
J Med Chem. 1995 Aug 18;38(17):3297-312. doi: 10.1021/jm00017a015.
The antispastic agent and muscle relaxant baclofen 1 is a potent and selective agonist for bicuculline-insensitive GABAB receptors. For many years efforts to obtain superior GABAB agonists were unsuccessful. We describe the syntheses and biological properties of two new series of GABAB agonists, the best compounds of which are more potent than baclofen in vitro and in vivo. They were obtained by replacing the carboxylic acid group of GABA or baclofen derivatives with either the phosphinic acid or the methylphosphinic acid residue. Surprisingly, ethyl- and higher alkylphosphinic acid derivatives of GABA yielded novel GABAB antagonists, which are described in part 2 of this series. Structure-activity relationships of the novel GABAB agonists are discussed with respect to their affinities to GABAB receptors as well as to their effects in many functional tests in vitro and in vivo providing new muscle relaxant drugs with significantly improved side effect profiles.
抗痉挛药和肌肉松弛剂巴氯芬1是对荷包牡丹碱不敏感的GABAB受体的强效选择性激动剂。多年来,研发更优GABAB激动剂的努力均未成功。我们描述了两个新系列GABAB激动剂的合成及生物学特性,其中最佳化合物在体外和体内均比巴氯芬更有效。它们是通过用次膦酸或甲基次膦酸残基取代GABA或巴氯芬衍生物的羧酸基团而获得的。令人惊讶的是,GABA的乙基及更高烷基次膦酸衍生物产生了新型GABAB拮抗剂,本系列第2部分对此进行了描述。就新型GABAB激动剂对GABAB受体的亲和力以及它们在许多体外和体内功能测试中的作用,讨论了构效关系,从而提供了副作用明显改善的新型肌肉松弛药物。